Coronavirus: A Laboratory Perspective
Ransom Baribefii Jacob, Chukwu Christopher Ifunaya, Emeji Roseline
International Blood Research & Reviews · pp. 1–7 · Published 2 Aug 2021
10.9734/ibrr/2021/v12i430155Abstract
COVID-19 is a virus of the species of the Family coronaviridae known as as SARS-COV-2. This virus is easily contracted and/transmitted from an infected person to another healthy individual and has continued to spread rapidly. The aim of this review is to identify laboratory methods used in the diagnosis of COVID-19 infection. COVID-19 test are aimed at detecting active infection, or past infection, or an immunization so as to treat and curb the further spread of the virus. The initial viral detection is typically carried out with the upper respiratory tract (URT) sample. Repeated testing is particularly helpful and essential if a patient has a clinical appearance of viral pneumonia, radiographic results consistent with pneumonia and/or a history of potential exposure. The Centre of Disease Control and Prevention, CDC recommends the collection of specimens from the lower respiratory tract, upper respiratory tract, and the blood. The lower respiratory tract sample includes; the sputum, broncheoalveolar lavage, bronchial wash, tracheal aspirate, and pleural fluid. The upper respiratory tract specimens include; the nasopharyngeal swab, and oropharyngeal swab (NP/OP swabs). Some laboratory techniques developed and in use for the detection of Covid-19 are; nucleic acid amplification tests (NAATs), antibody detection, and viral antigen detection. The role of the laboratory assay in diagnosis of COVID-19 infection or disease cannot be under-estimated, timing and site of specimen collected must be followed by adequate professional training to ensure result accuracy. This review provides information on available laboratory techniques for the diagnosis of the viral infection and their potential merits and limitations.
References (17)
- 1 Detection of SARS-CoV-2 in Different Types of Clinical Specimens [DOI]
- 2 Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility [DOI]
- 3 Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore [DOI]
- 4 Isothermal Amplification of Nucleic Acids [DOI]
- 5 Viral load of SARS-CoV-2 in clinical samples [DOI]
- 6 Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia [DOI]
- 7 Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2 [DOI]
- 8 SARS-CoV-2 detection, viral load and infectivity over the course of an infection [DOI]
- 9 Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus 2 [DOI]
- 10 Profile of RT-PCR for SARS-CoV-2: A Preliminary Study From 56 COVID-19 Patients [DOI]
- 11 Review of Current Advances in Serologic Testing for COVID-19 [DOI]
- 12 The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: A systematic review [DOI]
- 13 SARS‐CoV ‐2 asymptomatic and symptomatic patients and risk for transfusion transmission [DOI]
- 14 Laboratory Diagnosis of COVID-19: Current Issues and Challenges [DOI]
- 15 Fast, portable tests come online to curb coronavirus pandemic [DOI]
- 16 Test performance evaluation of SARS-CoV-2 serological assays [DOI]
- 17 SARS-CoV-2 asymptomatic and symptomatic patients and risk for transfusion transmission [DOI]
Cited by 0
No indexed citations yet.
Related research
- Covid-2019:“A Microbiological Monster” — shares topic coverage
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): What Can Africa Learn from Ongoing Research in Epidemiology, Clinical Manifestations, Chemotherapy and Prevention? — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Early Treatment with Hydroxychloroquine Improves Clinical Outcomes and Reduces Hospital Admissions in COVID-19 Associated Pneumonia — shares topic coverage
Article metrics
Real usage data collected on this platform.
29
Page views
0
PDF downloads
3
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.